AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-84
Results: 1-25/84
INTERLEUKIN-6-TYPE CYTOKINES STIMULATE MESENCHYMAL PROGENITOR DIFFERENTIATION TOWARD THE OSTEOBLASTIC LINEAGE
Authors: TAGUCHI Y YAMAMOTO M YAMATE T LIN SC MOCHARLA H DETOGNI P NAKAYAMA N BOYCE BF ABE E MANOLAGAS SC
Citation: Y. Taguchi et al., INTERLEUKIN-6-TYPE CYTOKINES STIMULATE MESENCHYMAL PROGENITOR DIFFERENTIATION TOWARD THE OSTEOBLASTIC LINEAGE, Proceedings of the Association of American Physicians, 110(6), 1998, pp. 559-574
OSTEOBLAST PROGRAMMED CELL-DEATH (APOPTOSIS) - MODULATION BY GROWTH-FACTORS AND CYTOKINES
Authors: JILKA RL WEINSTEIN RS BELLIDO T PARFITT AM MANOLAGAS SC
Citation: Rl. Jilka et al., OSTEOBLAST PROGRAMMED CELL-DEATH (APOPTOSIS) - MODULATION BY GROWTH-FACTORS AND CYTOKINES, Journal of bone and mineral research, 13(5), 1998, pp. 793-802
CELLULAR AND MOLECULAR MECHANISMS OF OSTEOPOROSIS
Authors: MANOLAGAS SC
Citation: Sc. Manolagas, CELLULAR AND MOLECULAR MECHANISMS OF OSTEOPOROSIS, Aging, 10(3), 1998, pp. 182-190
INHIBITION OF OSTEOBLASTOGENESIS AND PROMOTION OF APOPTOSIS OF OSTEOBLASTS AND OSTEOCYTES BY GLUCOCORTICOIDS - POTENTIAL MECHANISMS OF THEIR DELETERIOUS EFFECTS ON BONE
Authors: WEINSTEIN RS JILKA RL PARFITT AM MANOLAGAS SC
Citation: Rs. Weinstein et al., INHIBITION OF OSTEOBLASTOGENESIS AND PROMOTION OF APOPTOSIS OF OSTEOBLASTS AND OSTEOCYTES BY GLUCOCORTICOIDS - POTENTIAL MECHANISMS OF THEIR DELETERIOUS EFFECTS ON BONE, The Journal of clinical investigation, 102(2), 1998, pp. 274-282
LOSS OF ESTROGEN UP-REGULATES OSTEOBLASTOGENESIS IN THE MURINE BONE-MARROW - EVIDENCE FOR AUTONOMY FROM FACTORS RELEASED DURING BONE-RESORPTION
Authors: JILKA RL TAKAHASHI K MUNSHI M WILLIAMS DC ROBERSON PK MANOLAGAS SC
Citation: Rl. Jilka et al., LOSS OF ESTROGEN UP-REGULATES OSTEOBLASTOGENESIS IN THE MURINE BONE-MARROW - EVIDENCE FOR AUTONOMY FROM FACTORS RELEASED DURING BONE-RESORPTION, The Journal of clinical investigation, 101(9), 1998, pp. 1942-1950
TRANSCRIPTIONAL ACTIVATION OF THE P21(WAF1,CIP1,SDI1) GENE BY INTERLEUKIN-6 TYPE CYTOKINES - A PREREQUISITE FOR THEIR PRO-DIFFERENTIATING AND ANTI-APOPTOTIC EFFECTS ON HUMAN OSTEOBLASTIC CELLS
Authors: BELLIDO T OBRIEN CA ROBERSON PK MANOLAGAS SC
Citation: T. Bellido et al., TRANSCRIPTIONAL ACTIVATION OF THE P21(WAF1,CIP1,SDI1) GENE BY INTERLEUKIN-6 TYPE CYTOKINES - A PREREQUISITE FOR THEIR PRO-DIFFERENTIATING AND ANTI-APOPTOTIC EFFECTS ON HUMAN OSTEOBLASTIC CELLS, The Journal of biological chemistry, 273(33), 1998, pp. 21137-21144
THE PATHOPHYSIOLOGIC ROLES OF INTERLEUKIN-6 IN HUMAN-DISEASE
Authors: PAPANICOLAOU DA WILDER RL MANOLAGAS SC CHROUSOS GP
Citation: Da. Papanicolaou et al., THE PATHOPHYSIOLOGIC ROLES OF INTERLEUKIN-6 IN HUMAN-DISEASE, Annals of internal medicine, 128(2), 1998, pp. 127-137
PATHOGENESIS AND MANAGEMENT OF BONE-LESIONS IN MULTIPLE-MYELOMA
Authors: BATAILLE R MANOLAGAS SC BERENSON JR
Citation: R. Bataille et al., PATHOGENESIS AND MANAGEMENT OF BONE-LESIONS IN MULTIPLE-MYELOMA, Hematology/oncology clinics of North America, 11(2), 1997, pp. 349
QUANTIFICATION OF VITAMIN-D-RECEPTOR MESSENGER-RNA BY COMPETITIVE POLYMERASE-CHAIN-REACTION IN PBMC - LACK OF CORRESPONDENCE WITH COMMON ALLELIC VARIANTS
Authors: MOCHARLA H BUTCH AW PAPPAS AA FLICK JT WEINSTEIN RS DETOGNI P JILKA RL ROBERSON PK PARFITT AM MANOLAGAS SC
Citation: H. Mocharla et al., QUANTIFICATION OF VITAMIN-D-RECEPTOR MESSENGER-RNA BY COMPETITIVE POLYMERASE-CHAIN-REACTION IN PBMC - LACK OF CORRESPONDENCE WITH COMMON ALLELIC VARIANTS, Journal of bone and mineral research, 12(5), 1997, pp. 726-733
INCREASED ADIPOGENESIS AND MYELOPOIESIS IN THE BONE-MARROW OF SAMP6, A MURINE MODEL OF DEFECTIVE OSTEOBLASTOGENESIS AND LOW TURNOVER OSTEOPENIA
Authors: KAJKENOVA O LECKACZERNIK B GUBRIJ I HAUSER SP TAKAHASHI K PARFIT AM JILKA RL MANOLAGAS SC LIPSCHITZ DA
Citation: O. Kajkenova et al., INCREASED ADIPOGENESIS AND MYELOPOIESIS IN THE BONE-MARROW OF SAMP6, A MURINE MODEL OF DEFECTIVE OSTEOBLASTOGENESIS AND LOW TURNOVER OSTEOPENIA, Journal of bone and mineral research, 12(11), 1997, pp. 1772-1779
INTERLEUKIN-6 MEDIATES PTH-INDUCED BONE-RESORPTION IN-VIVO
Authors: GREY A MITNICK M MANOLAGAS SC JILKA RL INSOGNA K
Citation: A. Grey et al., INTERLEUKIN-6 MEDIATES PTH-INDUCED BONE-RESORPTION IN-VIVO, Journal of bone and mineral research, 12, 1997, pp. 40-40
GLUCOCORTICOID EXCESS CAUSES APOPTOSIS OF OSTEOCYTES IN MURINE CORTICAL BONE - A POTENTIAL EXPLANATION FOR BONE NECROSIS
Authors: WEINSTEIN RS JILKA RL MILLER FL PARFITT AM MANOLAGAS SC
Citation: Rs. Weinstein et al., GLUCOCORTICOID EXCESS CAUSES APOPTOSIS OF OSTEOCYTES IN MURINE CORTICAL BONE - A POTENTIAL EXPLANATION FOR BONE NECROSIS, Journal of bone and mineral research, 12, 1997, pp. 158-158
GP130 STAT3 ACTIVATION STIMULATES THE TRANSCRIPTION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21(WAF1,CIP1) GENE IN OSTEOBLASTS - A PREREQUISITE FOR THE BIOLOGIC EFFECTS OF IL-6 TYPE CYTOKINES/
Authors: BELLIDO T HAN L JILKA RL MANOLAGAS SC
Citation: T. Bellido et al., GP130 STAT3 ACTIVATION STIMULATES THE TRANSCRIPTION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21(WAF1,CIP1) GENE IN OSTEOBLASTS - A PREREQUISITE FOR THE BIOLOGIC EFFECTS OF IL-6 TYPE CYTOKINES/, Journal of bone and mineral research, 12, 1997, pp. 232-232
GLUCOCORTICOID EXCESS DECREASES THE NUMBER OF OSTEOBLAST PROGENITORS IN THE MARROW AND INCREASES MATURE OSTEOBLAST APOPTOSIS IN MICE
Authors: WEINSTEIN RS JILKA RL YOUNG C MILLER FL SHELTON R SMITH C PARFITT AM MANOLAGAS SC
Citation: Rs. Weinstein et al., GLUCOCORTICOID EXCESS DECREASES THE NUMBER OF OSTEOBLAST PROGENITORS IN THE MARROW AND INCREASES MATURE OSTEOBLAST APOPTOSIS IN MICE, Journal of bone and mineral research, 12, 1997, pp. 256-256
DIVERGENT EFFECTS OF ESTROGEN AND TGF-BETA ON MURINE BONE-MARROW CELLS
Authors: DIGREGORIO G MOCHARLA H BONNER M MANOLAGAS SC JILKA RL
Citation: G. Digregorio et al., DIVERGENT EFFECTS OF ESTROGEN AND TGF-BETA ON MURINE BONE-MARROW CELLS, Journal of bone and mineral research, 12, 1997, pp. 306-306
ATTENUATION OF OSTEOBLASTOGENESIS IN THE MURINE BONE-MARROW BY INHIBIN AND FOLLISTATIN - EVIDENCE FOR DISTINCT EFFECTS AT DIFFERENT STAGES OF THE PROCESS
Authors: GADDYKURTEN D COKER JK VAUGHAN JM VALE WW JILKA RL MANOLAGAS SC
Citation: D. Gaddykurten et al., ATTENUATION OF OSTEOBLASTOGENESIS IN THE MURINE BONE-MARROW BY INHIBIN AND FOLLISTATIN - EVIDENCE FOR DISTINCT EFFECTS AT DIFFERENT STAGES OF THE PROCESS, Journal of bone and mineral research, 12, 1997, pp. 316-316
NOGGIN, A NATURAL ANTAGONIST OF BMP ACTION, PREVENTS OSTEOBLAST DEVELOPMENT FROM MURINE BONE-MARROW PROGENITORS OF ADULT MICE
Authors: ABE E TAGUCHI Y YAMAMOTA M STAHL N YANCOPOULOS G JILKA RL MANOLAGAS SC
Citation: E. Abe et al., NOGGIN, A NATURAL ANTAGONIST OF BMP ACTION, PREVENTS OSTEOBLAST DEVELOPMENT FROM MURINE BONE-MARROW PROGENITORS OF ADULT MICE, Journal of bone and mineral research, 12, 1997, pp. 320-320
ISOLATION OF CLONAL CELL-LINES WITH DISTINCT DIFFERENTIATION POTENTIAL TOWARD OSTEOBLASTS, ADIPOCYTES, OR BOTH - ASSOCIATION OF THE OSTEOCLAST SUPPORT FUNCTION WITH BIPOTENTIALITY
Authors: GUBRIJ I LECKACZERNIK B KAJKENOVA O MOERMAN E OBRIEN C LIPSCHITZ D MANOLAGAS SC JILKA RL
Citation: I. Gubrij et al., ISOLATION OF CLONAL CELL-LINES WITH DISTINCT DIFFERENTIATION POTENTIAL TOWARD OSTEOBLASTS, ADIPOCYTES, OR BOTH - ASSOCIATION OF THE OSTEOCLAST SUPPORT FUNCTION WITH BIPOTENTIALITY, Journal of bone and mineral research, 12, 1997, pp. 327-327
ISOLATION AND CHARACTERIZATION OF A BONE-MARROW-DERIVED MURINE CELL-LINE ABLE TO DIFFERENTIATE INTO EITHER FAT-LADEN ADIPOCYTES OR MINERALIZING OSTEOBLASTS
Authors: LECKACZERNIK B GUBRIJ I MOERMAN E KAJKENOVA O MANOLAGAS SC JILKA RL LIPSCHITZ D
Citation: B. Leckaczernik et al., ISOLATION AND CHARACTERIZATION OF A BONE-MARROW-DERIVED MURINE CELL-LINE ABLE TO DIFFERENTIATE INTO EITHER FAT-LADEN ADIPOCYTES OR MINERALIZING OSTEOBLASTS, Journal of bone and mineral research, 12, 1997, pp. 328-328
DECREASE OF EFFECTIVE GP130 LEVELS BY A DOMINANT-NEGATIVE MUTANT ATTENUATES IL-6-INDUCED STAT ACTIVATION
Authors: LIN SC OBRIEN CA MANOLAGAS SC
Citation: Sc. Lin et al., DECREASE OF EFFECTIVE GP130 LEVELS BY A DOMINANT-NEGATIVE MUTANT ATTENUATES IL-6-INDUCED STAT ACTIVATION, Journal of bone and mineral research, 12, 1997, pp. 330-330
GENERATION OF MICE HARBORING AN IL-6 PROMOTER-LUCIFERASE TRANSGENE THAT MIMICS ENDOGENOUS IL-6 GENE-REGULATION
Authors: OBRIEN CA JILKA RL MANOLAGAS SC
Citation: Ca. Obrien et al., GENERATION OF MICE HARBORING AN IL-6 PROMOTER-LUCIFERASE TRANSGENE THAT MIMICS ENDOGENOUS IL-6 GENE-REGULATION, Journal of bone and mineral research, 12, 1997, pp. 331-331
DEXAMETHASONE PROMOTES APOPTOSIS OF OSTEOBLAST PROGENITORS IN MURINE BONE-MARROW CULTURES - ANTAGONISM BY IL-6 TYPE CYTOKINES
Authors: JILKA RL SMITH C MANOLAGAS SC
Citation: Rl. Jilka et al., DEXAMETHASONE PROMOTES APOPTOSIS OF OSTEOBLAST PROGENITORS IN MURINE BONE-MARROW CULTURES - ANTAGONISM BY IL-6 TYPE CYTOKINES, Journal of bone and mineral research, 12, 1997, pp. 411-411
GENETIC-MAPPING OF OSTEOPENIA-ASSOCIATED LOCI USING CROSSES BETWEEN CLOSELY-RELATED MOUSE STRAINS WITH DIFFERING BONE-MINERAL DENSITY
Authors: BENES H DENNIS R ZHENG W WEINSTEIN RS SHELTON R JILKA RL ROBERSON P MANOLAGAS SC REIS RJS
Citation: H. Benes et al., GENETIC-MAPPING OF OSTEOPENIA-ASSOCIATED LOCI USING CROSSES BETWEEN CLOSELY-RELATED MOUSE STRAINS WITH DIFFERING BONE-MINERAL DENSITY, Journal of bone and mineral research, 12, 1997, pp. 598-598
REGULATION OF THE GP80 AND GP130 SUBUNITS OF THE IL-6 RECEPTOR BY SEXSTEROIDS IN THE MURINE BONE-MARROW
Authors: LIN SC YAMATE T TAGUCHI Y BORBA VZC GIRASOLE G OBRIEN CA BELLIDO T ABE E MANOLAGAS SC
Citation: Sc. Lin et al., REGULATION OF THE GP80 AND GP130 SUBUNITS OF THE IL-6 RECEPTOR BY SEXSTEROIDS IN THE MURINE BONE-MARROW, The Journal of clinical investigation, 100(8), 1997, pp. 1980-1990
REGULATION OF THE GP80 AND GP130 SUBUNITS OF THE IL-6 RECEPTOR BY SEXSTEROIDS IN THE MURINE BONE-MARROW (VOL 100, PG 1980, 1997)
Authors: LIN SC YAMATE T TAGUCHI Y BORBA VZC GIRASOLE G OBRIEN CA BELLIDO T ABE E MANOLAGAS SC
Citation: Sc. Lin et al., REGULATION OF THE GP80 AND GP130 SUBUNITS OF THE IL-6 RECEPTOR BY SEXSTEROIDS IN THE MURINE BONE-MARROW (VOL 100, PG 1980, 1997), The Journal of clinical investigation, 100(11), 1997, pp. 2933-2933
Risultati: 1-25 | 26-50 | 51-75 | 76-84